Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Best Practice & Research. Clinical Endocrinology & Metabolism|November 10, 2004
Clinical endocrinology and metabolism. Potential clinical applications of vasoactive intestinal peptide: a selected updateIllana Gozes, Sharon FurmanJournal of Molecular Neuroscience : MN|January 25, 2014
NAP alpha-aminoisobutyric acid (IsoNAP)Illana Gozes, Yulie Schirer, Anat Idan-Feldman, et al.Journal of Molecular Neuroscience : MN|September 6, 2002
NAP accelerates the performance of normal rats in the water mazeIllana Gozes, Roy Alcalay, Eliezer Giladi, et al.Expert Opinion on Therapeutic Targets|May 17, 2007
The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma QuigleyIllana GozesThe EPMA Journal|December 4, 2012
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practiceIllana GozesNeuron Glia Biology|July 18, 2006
Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytesSharon Furman, Ruth A Steingart, Shmuel Mandel, et al.Biological Chemistry|May 9, 2015
The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNPIllana GozesCurrent Pharmaceutical Design|April 29, 2011
NAP (davunetide) provides functional and structural neuroprotectionIllana GozesCurrent Pharmaceutical Design|September 10, 2011
Microtubules (tau) as an emerging therapeutic target: NAP (davunetide)Illana GozesPageof 20